[go: up one dir, main page]

NO904285L - Fremgangsmaate for fremstilling av substituerte karboksytetrahydroisokinoliner. - Google Patents

Fremgangsmaate for fremstilling av substituerte karboksytetrahydroisokinoliner.

Info

Publication number
NO904285L
NO904285L NO90904285A NO904285A NO904285L NO 904285 L NO904285 L NO 904285L NO 90904285 A NO90904285 A NO 90904285A NO 904285 A NO904285 A NO 904285A NO 904285 L NO904285 L NO 904285L
Authority
NO
Norway
Prior art keywords
carboxytetrahydroisokinolines
substituted
procedure
preparation
substituted carboxytetrahydroisokinolines
Prior art date
Application number
NO90904285A
Other languages
English (en)
Other versions
NO904285D0 (no
Inventor
Graham Johnson
Thomas Charles Malone
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of NO904285D0 publication Critical patent/NO904285D0/no
Publication of NO904285L publication Critical patent/NO904285L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids
    • C07C271/08Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/26Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4015Esters of acyclic unsaturated acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4021Esters of aromatic acids (P-C aromatic linkage)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4056Esters of arylalkanephosphonic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576Six-membered rings
    • C07F9/62Isoquinoline or hydrogenated isoquinoline ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO90904285A 1989-10-03 1990-10-02 Fremgangsmaate for fremstilling av substituerte karboksytetrahydroisokinoliner. NO904285L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US41668489A 1989-10-03 1989-10-03

Publications (2)

Publication Number Publication Date
NO904285D0 NO904285D0 (no) 1990-10-02
NO904285L true NO904285L (no) 1991-04-04

Family

ID=23650893

Family Applications (1)

Application Number Title Priority Date Filing Date
NO90904285A NO904285L (no) 1989-10-03 1990-10-02 Fremgangsmaate for fremstilling av substituerte karboksytetrahydroisokinoliner.

Country Status (10)

Country Link
EP (1) EP0421436A3 (no)
JP (1) JPH03120254A (no)
KR (1) KR910007885A (no)
AU (1) AU6368090A (no)
CA (1) CA2026680A1 (no)
FI (1) FI904838A0 (no)
IE (1) IE903528A1 (no)
NO (1) NO904285L (no)
PT (1) PT95487A (no)
ZA (1) ZA907870B (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4902695A (en) * 1989-02-13 1990-02-20 Eli Lilly And Company Excitatory amino acid receptor antagonists
DE4104257A1 (de) * 1991-02-13 1992-08-20 Boehringer Ingelheim Kg Verwendung von anellierten tetrahydropyridinessigsaeurederivaten fuer die behandlung neurologischer erkrankungen
DE19605766A1 (de) * 1996-02-16 1997-08-21 Basf Ag Substituierte 2-Phenylpyridine
EP1019378B1 (en) * 1996-07-01 2004-09-29 Eli Lilly And Company Hypoglycemic and hypolipidemic compounds
EP1280777B1 (en) 2000-05-11 2005-11-23 Bristol-Myers Squibb Company Tetrahydroisoquinoline analogs useful as growth hormone secretagogues
WO2003041641A2 (en) 2001-11-09 2003-05-22 Bristol-Myers Squibb Company Tetrahydroisoquinoline analogs as modulators of chemokine receptor activity
MX2007000428A (es) 2004-07-15 2008-03-05 Amr Technology Inc Tetrahidroisoquinolinas sustituidas con arilo y heteroarilo y uso de las mismas para bloquear la captacion de norepinefrina, dopamina y serotonina.
US9156812B2 (en) 2008-06-04 2015-10-13 Bristol-Myers Squibb Company Crystalline form of 6-[(4S)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amine
US10499694B2 (en) 2008-08-01 2019-12-10 Nike, Inc. Apparel with selectively attachable and detachable elements
US20100024089A1 (en) 2008-08-01 2010-02-04 Nike, Inc. Apparel With Selectively Attachable And Detachable Elements
US8898820B2 (en) 2008-08-01 2014-12-02 Nike, Inc. Layered apparel with attachable and detachable elements
KR20120023072A (ko) 2009-05-12 2012-03-12 브리스톨-마이어스 스큅 컴퍼니 (S)-7-(〔1,2,4〕트리아졸〔1,5-a〕피리딘-6-일)-4-(3,4-디클로로페닐)-1,2,3,4-테트라하이드로이소퀴놀린의 결정형 및 이의 용도
MX2011011907A (es) 2009-05-12 2012-01-20 Albany Molecular Res Inc 7-([1,2,4,]triazolo[1,5-a]piridin-6-il)-4-(3,4-diclorofenil)-1,2, 3,4-tetrahidroisoquinolina y uso de la misma.
MX2011011901A (es) 2009-05-12 2012-01-20 Albany Molecular Res Inc Tetrahidroisoquinolinas aril, heteroaril, y heterociclo sustituidas y uso de las mismas.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8801491D0 (en) * 1988-01-22 1988-02-24 Beecham Group Plc Novel compounds
CA2000901A1 (en) * 1988-10-21 1990-04-21 Alexis A. Cordi Phosphono-hydroisoquinoline compounds useful in reducing neurotoxic injury

Also Published As

Publication number Publication date
EP0421436A3 (en) 1992-03-11
JPH03120254A (ja) 1991-05-22
CA2026680A1 (en) 1991-04-04
AU6368090A (en) 1991-04-11
NO904285D0 (no) 1990-10-02
IE903528A1 (en) 1991-04-10
EP0421436A2 (en) 1991-04-10
PT95487A (pt) 1991-08-14
KR910007885A (ko) 1991-05-30
FI904838A0 (fi) 1990-10-01
ZA907870B (en) 1992-06-24

Similar Documents

Publication Publication Date Title
NO900830L (no) Fremgangsmaate for fremstilling av piperidinforbindelser.
NO904987L (no) Fremgangsmaate for fremstilling av indolderivater.
NO902003D0 (no) Fremgangsmaate for fremstilling av n-heteroaryl-4-quinolinaminer.
NO885454L (no) Fremgangsmaate for fremstilling av triklormonosilan.
NO901554D0 (no) Fremgangsmaate for fremstilling av dinatrium-cefodizim.
NO894210L (no) Fremgangsmaate for fremstilling av kinolyloxazol-2-oner.
NO904285L (no) Fremgangsmaate for fremstilling av substituerte karboksytetrahydroisokinoliner.
NO903431L (no) Fremgangsmaate for fremstilling av kromanderivater.
NO903275L (no) Fremgangsmaate for fremstilling av kromanderivater.
NO905377D0 (no) Fremgangsmaate for fremstilling av glycerolderivater.
NO895032D0 (no) Fremgangsmaate for fremstilling av 2-benzotiazoliner.
NO903043L (no) Fremgangsmaate for fremstilling av kromanderivater.
NO890159L (no) Fremgangsmaate for fremstilling av 1-alkyl-5-nitroimidazoler.
NO903207L (no) Fremgangsmaate for fremstilling av halogenaminoaromatiske derivater.
NO901067D0 (no) Fremgangsmaate for fremstilling av tiofener.
NO903666L (no) Fremgangsmaate for fremstilling av pyrrolokinolinforbindelser.
NO902762D0 (no) Fremgangsmaate for fremstilling av 5-fenyl-2-furan derivater.
NO904060D0 (no) Fremgangsmaate for fremstilling av substituerte dibenzofuraner.
NO900969L (no) Fremgangsmaate for fremstilling av n-allymetatrifluormetylanilin.
NO904535L (no) Fremgangsmaate for fremstilling av fenoksy-heterocykliske forbindelser.
NO905047D0 (no) Fremgangsmaate for fremstilling av selenofenderivater.
NO904070L (no) Fremgangsmaate for fremstilling av alkanfenoner.
NO890538L (no) Fremgangsmaate for fremstilling av oxadiazolyl-azabicyclo-heptaner.
NO920207L (no) Fremgangsmaate for fremstilling av 6-methyl-oestra-4,6-diener
NO904362L (no) Fremgangsmaate for fremstilling av kromanderivater.